A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine (Lu AA21004), on Actual Driving and Cognition

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

(2012) Cornelius Katona et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

(2011) Enric Alvarez et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

(2011) Benny Bang-Andersen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

(2011) Johannes G. Ramaekers et al.   PSYCHOPHARMACOLOGY

Productivity Losses Among Treated Depressed Patients Relative to Healthy Controls

(2010) Suellen Curkendall et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

(2009) I. Hindmarch   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

P.2.b.015 Lu AA21004: a novel potential treatment for mood disorders

(2008) N. Moore et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY